Cytokinetics (CYTK) PT Raised to $84 at Truist Securities
Tweet Send to a Friend
(Updated - December 23, 2025 9:25 AM EST)
Truist Securities analyst Srikripa Devarakonda raised the price target on Cytokinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda raised the price target on Cytokinetics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
